Anti-IL4RA/ IL4R/ CD124 monoclonal antibody

Anti-IL4RA/ IL4R/ CD124 antibody for FACS & in-vivo assay

Target products collectionGo to IL4R/IL4R products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T03346-Ab-1/ GM-Tg-hg-T03346-Ab-2Anti-Human IL4R monoclonal antibodyHuman
GM-Tg-rg-T03346-Ab-1/ GM-Tg-rg-T03346-Ab-2Anti-Rat IL4R monoclonal antibodyRat
GM-Tg-mg-T03346-Ab-1/ GM-Tg-mg-T03346-Ab-2Anti-Mouse IL4R monoclonal antibodyMouse
GM-Tg-cynog-T03346-Ab-1/ GM-Tg-cynog-T03346-Ab-2Anti-Cynomolgus/ Rhesus macaque IL4R monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T03346-Ab-1/ GM-Tg-felg-T03346-Ab-2Anti-Feline IL4R monoclonal antibodyFeline
GM-Tg-cang-T03346-Ab-1/ GM-Tg-cang-T03346-Ab-2Anti-Canine IL4R monoclonal antibodyCanine
GM-Tg-bovg-T03346-Ab-1/ GM-Tg-bovg-T03346-Ab-2Anti-Bovine IL4R monoclonal antibodyBovine
GM-Tg-equg-T03346-Ab-1/ GM-Tg-equg-T03346-Ab-2Anti-Equine IL4R monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T03346-Ab-1/ GM-Tg-hg-T03346-Ab-2; GM-Tg-rg-T03346-Ab-1/ GM-Tg-rg-T03346-Ab-2;
GM-Tg-mg-T03346-Ab-1/ GM-Tg-mg-T03346-Ab-2; GM-Tg-cynog-T03346-Ab-1/ GM-Tg-cynog-T03346-Ab-2;
GM-Tg-felg-T03346-Ab-1/ GM-Tg-felg-T03346-Ab-2; GM-Tg-cang-T03346-Ab-1/ GM-Tg-cang-T03346-Ab-2;
GM-Tg-bovg-T03346-Ab-1/ GM-Tg-bovg-T03346-Ab-2; GM-Tg-equg-T03346-Ab-1/ GM-Tg-equg-T03346-Ab-2
Products NameAnti-IL4R monoclonal antibody
Formatmab
Target NameIL4R
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL4R benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-680Pre-Made Manfidokimab biosimilar, Whole mAb, Anti-IL4R Antibody: Anti-CD124 therapeutic antibody
    BiosimilarGMP-Bios-ab-158Pre-Made Dupilumab biosimilar, Whole mAb, Anti-IL4R Antibody: Anti-CD124 therapeutic antibody
    Target AntigenProducts DevelopingMulti-species IL4RA/ IL4R/ CD124 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T03346
    Target NameIL4R
    Gene ID3566,16190,25084,705404,489957,101096277,404154,791252
    Gene Symbol and SynonymsCD124,IL-4RA,IL4R,IL4RA
    Uniprot AccessionP24394,Q63257,Q6WG24
    Uniprot Entry NameIL4RA_HUMAN,IL4RA_RAT,IL4RA_HORSE
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index
    Diseaseatopic asthma
    Gene EnsemblENSG00000077238
    Target ClassificationCheckpoint-Immuno Oncology

    The target: IL4R, gene name: IL4R, also named as CD124, IL-4RAA, IL4R. This gene encodes the alpha chain of the interleukin-4 receptor, a type I transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate IgE production. The encoded protein also can bind interleukin 4 to promote differentiation of Th2 cells. A soluble form of the encoded protein can be produced by proteolysis of the membrane-bound protein, and this soluble form can inhibit IL4-mediated cell proliferation and IL5 upregulation by T-cells. Allelic variations in this gene have been associated with atopy, a condition that can manifest itself as allergic rhinitis, sinusitus, asthma, or eczema. Polymorphisms in this gene are also associated with resistance to human immunodeficiency virus type-1 infection. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.